The XFG ("Stratus") Variant Explained: What It Means for the UK in 2026

XFG, informally nicknamed "Stratus" in media coverage, is a coronavirus lineage that has become one of the most commonly detected strains in the UK through the 2025 to 2026 season. Like every variant since 2021, it descends from the Omicron family of SARS-CoV-2, rather than being an entirely new virus.

What XFG actually is

XFG is what's known as a recombinant variant, meaning it emerged when two earlier Omicron sub-variants exchanged genetic material during a co-infection in a single host. This is a well-documented, fairly routine way for coronaviruses to evolve and it isn't unique or unusually alarming on its own. According to UK Health Security Agency (UKHSA) surveillance data, XFG became the most prevalent lineage detected in the UK from around July 2025 onwards and it has continued to circulate widely alongside other lineages into 2026.

Why it spreads effectively

UKHSA's monitoring points to enhanced immune escape as the main reason XFG has spread so effectively. In simple terms, this means the variant carries mutations that make it somewhat better at evading antibodies built up from earlier infections or vaccinations, allowing it to reinfect people more easily than some earlier strains. This doesn't mean vaccines or prior immunity offer no protection. It means the protection against catching the virus at all is reduced, while protection against severe illness generally holds up better.

Is it more severe than earlier variants?

Based on current UKHSA data, there's no clear evidence that XFG causes more severe illness than the variants that circulated immediately before it. Symptoms reported look broadly similar to other recent Omicron descendants: a high temperature, sore throat, cough, fatigue and, for some people, a change to their sense of taste or smell. As with any respiratory virus, individual experiences vary considerably depending on age, vaccination status and underlying health.

What UK surveillance shows

UKHSA tracks the prevalence of circulating variants through its national flu and COVID-19 surveillance reports, published regularly on GOV.UK. These reports use genomic sequencing of a sample of positive tests to estimate what proportion of current cases belong to each lineage. Prevalence naturally shifts week to week and season to season as new sub-variants emerge and older ones decline, so any single snapshot is a moment in an ongoing, normal pattern rather than a fixed state.

What this means for vaccination

Because variants like XFG continue to emerge and shift the immune landscape, COVID-19 vaccines used in the UK are periodically updated to better match currently circulating strains, similar to how the annual flu vaccine is reformulated each year. This is part of why booster doses remain available on a seasonal basis for eligible groups, including older adults and people with health conditions that increase their risk. Keeping up with recommended boosters, where you're eligible, remains one of the most effective ways to maintain protection against severe illness as the virus continues to evolve.

Frequently asked questions

Does XFG cause different symptoms to other variants?

Not in any way that's been clearly established. Symptoms reported with XFG largely overlap with those seen in other recent COVID-19 variants, making it very difficult to tell which specific variant you have from symptoms alone.

Will current vaccines still protect against XFG?

Updated vaccine formulations are designed to target the spike protein of currently circulating variants as closely as possible. Even where a precise match isn't perfect, vaccination has continued to provide meaningful protection against severe illness and hospitalisation.

Where can I check the latest variant data?

UKHSA publishes regular national flu and COVID-19 surveillance reports on GOV.UK, which include up to date variant prevalence figures for England.

How UKHSA classifies and names variants

Behind nicknames like "Stratus" sits a formal scientific naming system called Pango lineage classification, which tracks the genetic ancestry of SARS-CoV-2 as it mutates over time. A code such as XFG identifies a specific branch of that family tree. UKHSA, alongside international bodies including the World Health Organization, assesses new lineages against defined criteria covering transmissibility, immune escape and severity, categorising the most significant ones as variants under monitoring or, for those judged to pose a greater risk, variants of concern. As of current assessments, XFG hasn't been classified as a variant of concern, reflecting the absence of evidence for increased severity.

What to do if you catch it

There's no separate treatment pathway for a specific variant like XFG. If you test positive or develop symptoms, the same general guidance applies as for any COVID-19 infection: rest, stay hydrated, manage fever and aches with appropriate over-the-counter medication and avoid close contact with vulnerable people until you're feeling better. People in higher-risk groups who test positive may be eligible for antiviral treatment regardless of which specific variant is involved, so contacting your GP promptly remains worthwhile if you fall into one of those groups.

Frequently asked questions

Is XFG the only variant currently circulating?

No. XFG has circulated alongside other lineages, including NB.1.8.1 and the relative prevalence of each shifts over time as UKHSA's ongoing surveillance continues to track.

Will there be another named variant after XFG?

Almost certainly. SARS-CoV-2 continues to evolve incrementally, similar to other respiratory viruses and new lineages will keep emerging and being tracked by surveillance systems for the foreseeable future.

Common symptoms reported with XFG

Reports associated with XFG haven't pointed to a distinct symptom pattern separate from other recent Omicron-descended variants. Sore throat, fatigue, a runny or blocked nose, headache and muscle aches remain the most commonly reported symptoms, with the classic early-pandemic signs of loss of smell and taste now reported far less often. This pattern is broadly consistent across the currently circulating lineages, which is part of why testing remains the only reliable way to distinguish COVID-19 from other seasonal respiratory illnesses with similar symptoms.

Protecting yourself and others

The same sensible precautions that have applied throughout the pandemic remain relevant regardless of which specific variant is circulating. Washing your hands regularly, staying home when you're unwell, covering coughs and sneezes and ensuring indoor spaces are well ventilated all reduce the chance of passing on any respiratory virus, including whichever COVID-19 lineage happens to be most prevalent at the time. For anyone in a higher-risk group, keeping up to date with eligible vaccinations remains one of the most effective ways to reduce the risk of severe illness.

Where to find reliable updates

For anyone wanting to follow developments beyond what's covered here, UKHSA publishes regular surveillance reports summarising variant prevalence and other trends and these are freely available on GOV.UK. The NHS website is generally the most reliable place to check current vaccination eligibility and booking information, since it's kept up to date as programmes change. We'll continue to update our own coverage here as UKHSA's assessment of XFG and any newer lineages develops.

A quick recap

XFG, nicknamed Stratus, is a recently identified COVID-19 lineage being tracked by UKHSA as part of routine genomic surveillance. Current evidence hasn't linked it to more severe illness than other recent variants and the practical advice for anyone who catches it remains the same as for COVID-19 generally: rest, stay hydrated and seek medical advice if you're in a higher-risk group or your symptoms are severe or getting worse rather than better.